Sharma, Santosh Kumar
Vishwakarma, Deepanjali
Article History
Received: 27 July 2021
Accepted: 6 May 2022
First Online: 15 May 2022
Declarations
:
: The study did not require ethical approval or participant participation because it was a secondary data analysis of publicly available survey data from the MEASURE DHS programme. We asked DHS Program for permission to obtain and utilise the data from ExternalRef removed for this study, and they agreed. Procedures for DHS public-use datasets certified by the Institutional Review Board do not enable respondents, households, or sample communities to be identifiable in any way. In the data files, there are no names of persons or addresses of households. The ethical clearence was obtained from the IIPS-IRB board Mumbai, and the survey agencies that collected the data followed all the protocols as recommended by IIPS-IRB borad. The NFHS employed three consent forms in compliance with Human Subjects Protection: Household Informed Consent, Individual Informed Consent, and Consent for Blood Samples Collection for Storage and Future Use (DBS). The study procedure was explained to each survey participant, and the stages of each biomarker test were shown by qualified health investigators. The interviews were conducted with the informed permission of the participants. It was possible for each participant to provide his or her consent because the survey obtained either signed or oral consent. All methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.